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Germ-lineZebraﬁsh transgenesis is a powerful and increasingly common strategy to assay vertebrate transcriptional
regulatory control. Several challenges remain, however, to the broader application of this technique; they
include increasing the rate with which transgenes can be analyzed and maximizing the informational value
of the data generated. Presently, many rely on the injection of individual constructs and the analysis of
resulting reporter expression in mosaic G0 embryos. Here, we contrast these approaches, examining whether
injecting pooled transgene constructs can increase the efﬁciency with which regulatory sequences can be
assayed, restricting analysis to the offspring of germ line transmitting transgenic zebraﬁsh in an effort to
reduce potential subjectivity. We selected a 64 kb interval encompassing the human ASCL1 locus as our
model interval and report the analysis of 9 highly conserved putative enhancers therein. We identiﬁed 32
transgene-positive zebraﬁsh, transmitting one or more independent constructs displaying ASCL1-like
regulatory control. Through examination of embryos harboring one or more transgenes, we demonstrate
that ﬁve of the nine sequences account for the observed control and describe their likely roles in ASCL1
regulation. These data demonstrate the utility of this approach and its potential for further adaptation and
higher throughput application.te of Genetic Medicine, Johns
, BRB Suite 449, Baltimore, MD
ey), andy@jhmi.edu
ll rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
Cis-regulation of transcription by noncoding DNA sequence plays
crucial roles in development [1–5], homeostasis [6,7], inter-species
variation [8–12], and disease risk [13–19]. In recent years regulatory
sequences such as enhancers have garneredmuch research interest and
commentary [20,21] and the repertoire of published enhancershas been
expanded by an increasing number of mid and large-scale transgenic
analyses performed in vivo [1,22–26]. These studies have recently been
complemented by efforts to integrate sequence conservation and
expression data with computational motif identiﬁcation and also by
analyses that have implemented emerging technologies like chromatin
immunoprecipitation (ChIP) based assays [27,28]. In combination these
new technologies have shown signiﬁcant promise in predicting tissue-
dependent enhancer function on a genome-wide scale. Importantly,
efforts to identify or validate predictions of regulatory sequences are in
large part dependent on transgenic strategies applied in multiple
vertebrate organisms and have been signiﬁcantly facilitated in their
application by recent improvements in technology and scale [29,30].
Mouse has for some time been considered the gold standard for
functional analyses, and as such has been favored by many labs fortransgenic studies of putative regulatory sequences. However, the
efﬁcacy of mouse transgenesis in high throughput applications is
blunted by cost and time constraints that cause many studies to be
restricted to transgenic analyses performed in G0 embryos at a single
developmental time point. Perhaps for this reason, among others,
transgenesis in non-mammalian vertebrates such as zebraﬁsh has
become an increasingly popular and powerful tool in these types of
studies. These organisms provide signiﬁcant cost beneﬁts and
facilitate analyses by live imaging at multiple time points during
development due to their external fertilization and transparent
embryos. As with mice, transgenic studies in zebraﬁsh frequently
rely on analyses performed in G0 embryos, which in the case of
zebraﬁsh can be highly mosaic. While this is a rapid and powerful
approach, themosaic nature of transgene expressionmakes it difﬁcult
to thoroughly characterize the regulatory control of a particular
sequence. Interpretation of these mosaic expression patterns relies
upon the documentation and integration of overlapping data from
signiﬁcant numbers of independent G0 embryos for any single
construct (Table S1). This yields a composite imputation of expression
that is inherently incomplete and makes scaling up to greater
numbers of elements all the more challenging [31].
By contrast, stable transgene transmission through the germ-line
allows a complete view of the tissue and temporal speciﬁc expression
pattern directed by each regulatory sequence. Its application in large-
scale studies however, has been limited, likely due to the added time
required to raise and screen offspring from identiﬁed transgene
“founders” and the inherent increased cost and space. Taken in
364 D.M. McGaughey, A.S. McCallion / Genomics 95 (2010) 363–369combination these issues compromise the rate at which one may
comprehensively assay sequences on the increasing scale required by
contemporary genomic analyses.
We wanted to assess whether a collection of putative regulatory
sequences could be reliably assayed in a single experiment, in contrast
to standard methods that introduce only one transgene per injection.
In an effort to address these issues we set out to develop an efﬁcient
strategy that focuses on analysis post germ line transmission and
pools constructs for injection. We have focused our efforts on the
human ASCL1 gene, encoding the Achaete-schute homolog 1. ASCL1 is
a member of the basic-helix-loop-helix (bHLH) family of transcription
factors that is required for development of many neural precursors,
including components of noradrenergic, serotonergic, sympathetic,
parasympathetic, and enteric neuronal populations [32–37]. Muta-
tions in ASCL1 have been associated with neuroendocrine tumors,
Central Congenital Hypoventilation Syndrome (CCHS), and Parkin-
son's disease [38–40]. This locus provides an ideal model for this effort
for a number of reasons. One enhancer has already been identiﬁed at
the mouse Ascl1 locus, and an interval encompassing the entire Ascl1
mouse locus was also shown to recapitulate much of the endogenous
expression [41,42]. These previous studies deﬁne an interval in which
we search for ASCL1 enhancers. Additionally, the relatively small
number of highly conserved sequences ﬂanking the ASCL1, its tightly
controlled expression during early development and the well-
documented expression of the ASCL1 orthologs in zebraﬁsh and
mice make it a good test case for this novel strategy [32,35].
We report the application of a novel transgenic pooling strategy in
the analysis of the human ASCL1 locus. We demonstrate that this
method allows for rapid validation of ASCL1 enhancers in stable
transgenic zebraﬁsh lines. The resulting transgenic composition of
identiﬁed zebraﬁsh is readily established by a PCR-based assay,
simplifying the necessary analyses and interpretation. We identify
ﬁve enhancers directing expression that overlaps ASCL1 and incom-
pletely overlap one another, postulating that they may act coopera-
tively to yield the spectrum of regulatory control displayed by the
endogenous ASCL1. In light of these datawe conclude that this method
can be used to efﬁciently analyze the regulatory potential of
numerous sequences in the offspring of germ-line transmitting
zebraﬁsh and eliminates many issues related to mosaic analyses.Fig. 1. Schematic of pooling strategy and selected amplicons of ASCL1 locus. A, Overview of po
the nine selected highly conserved amplicons are shown in green while two of the Verma-We, however, observe several complicating factors in these analyses
and propose several additional modiﬁcations that would facilitate
scaling to systematically address larger sets of sequences.Results
Development of a pooling transgenesis strategy
Zebraﬁsh transgenesis is an established and powerful strategy to
analyze transcriptional regulatory control however, most common
implementations share several limitations and bottlenecks. We, and
others, most frequently inject a single amplicon into 50-200 embryos,
creating mosaic transgenics. Currently, studies use either the
transgene expression proﬁle solely in the mosaic embryos or raise
selected transgene-positive embryos to sexual maturity for more
comprehensive reporter analysis. Although mosaic embryos can be
rapidly processed, their analysis is dependent on the determination of
composite signal across many embryos, leaving the interpretation
of their output somewhat subjective and incomplete. When analysis
of germ-line transmitted offspring is required, embryos injected with
individual constructs are raised discretely from other constructs,
which, in large numbers, can represent a strain on zebraﬁsh system
capacity. To increase the efﬁciency with which potential regulatory
noncoding sequences can be evaluated we set out to determine the
efﬁcacy of assaying pools of cloned sequences, injecting multiple
constructs simultaneously into zebraﬁsh embryos.
In this pilot pooling study, illustrated in Fig. 1A, we used as our test
case the human ASCL1 locus. We selected and pooled together ten
amplicons, nine selected sequences proximal to the ASCL1 locus and a
positive control sequence (zebraﬁsh phox2b -11.2; [26]) previously
demonstrated to direct robust expression discretely in the ventral
anterior spinal cord by 48 hours post fertilization (hpf). The nine test
sequences comprised the most highly conserved noncoding
sequences within a 64 kb interval encompassing ASCL1, scored by
28-species MultiZ alignment with PhastCons [43]. Sequences ranged
in size from 2.3 kilobases (kb) (ASCL1+54.4; the names are the
sequence's distance in kb from the transcriptional start site of ASCL1)
to 0.3 kb (ASCL1-1.4; Fig. 1B and Supplemental Table 2).oling strategy. B, The UCSC Genome Browser (genome.ucsc.edu) custom track (hg18) of
Kurvari et al. [42] orthologues are displayed in red overlayed onto the ASCL1 locus.
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eral transgenic LacZ reporter mouse lines containing up to 36 kb
encompassing this gene [41]. The largest transgene, J1A, directed near
complete Ascl1-like expression; the J1A interval is aligned to the
human ASCL1 locus (Fig. 1B) using the UCSC BLAT tool [44].
Additionally, smaller portions of the J1A transgene were subsequently
assessed, demonstrating that a 1.2 kb fragment (Transgene 14) also
directed tissue speciﬁc expression [42]. We generated an amplicon
encompassing sequence orthologous to Transgene 14 (ASCL1-6.1)
among our nine selected amplicons. All nine sequences were
subcloned into the pGWcfosGFP reporter construct [45].
We injected this pooled group of DNA into greater than 1000
zebraﬁsh embryos, screening all viable injected embryos at 24, 48, and
72 hpf. During screening, we selected ∼250 embryos displaying any
mosaic GFP reporter signal to raise to sexual maturity. These zebraﬁsh
were then out-crossed to AB stocks and their offspring were screened
for tissue speciﬁc expression of the GFP reporter. The patterns of
reporter expression displayed by the offspring from all identiﬁed
transgene-positive founder zebraﬁsh were documented (Fig. 2 and
Supplemental Fig. 1) and compared to endogenous ascl1 expression.
Expression pattern of zebraﬁsh ascl1a and asclb
Zebraﬁsh possess two orthologs of ASCL1, termed ascl1a and
ascl1b. The expression patterns of ascl1a and ascl1b have already been
extensively characterized [32]. ascl1a is expressed prominently in the
telencephalon, diencephalon, midbrain, and hindbrain at 24 and
48 hpf, accompanied by weaker expression in the spinal cord.
Additional expression can be found in the epiphysis, retina, and
sympathetic chain. The expression pattern of ascl1b is similar, but
expression in the spinal cord is more prominent than for ascl1a. To aid
our analyses we conducted in-situ hybridization of ascl1a (because of
its higher sequence identity to human ASCL1) on 24 and 48 hpf
zebraﬁsh embryos (Fig. 3).
Pooling transgenesis identiﬁes ﬁve putative enhancers directing ASCL1
consistent central neuronal expression patterns
Of the ∼250 zebraﬁsh we identiﬁed in our G0 screen, we out-
crossed 82 of the surviving mature male G0 zebraﬁsh with AB
females; their offspring were analyzed at 24, 48, and 72 hpf for tissue
speciﬁc expression of GFP. 36/82 (44%) of established crosses resultedFig. 2. Five ASCL1 amplicons direct tissue speciﬁc expression in embryonic zebraﬁsh. Lateral
oriented with the anterior to the left and posterior to the right. A, The -7.3 amplicon in zebra
amplicon in zebraﬁsh line 50 directs expression in the midbrain. C, The -1.4 amplicon in
D, The +3.3 amplicon in zebraﬁsh line 10 directs expression in the diencephalon, midb
expression in the epiphysis, midbrain, hindbrain, and spinal cord. Te, telencephalon; E, e
SC, spinal cord; [ marking SC expression region.in the identiﬁcation of embryos that displayed tissue speciﬁc
expression. To determine which of the putative ASCL1 enhancers
could contribute to reporter expression in each transgenic line, DNA
was extracted from GFP-positive G1 embryos and ampliﬁed indepen-
dently using primers speciﬁc to each amplicon. These genotyping
results, along with the tissues with GFP expression, are reported in
Table 1. Seven of the nine human ASCL1 amplicons (-7.3, -6.1, -1.4,
+3.3,+7.0,+13.2, +54.4, Table 1) and the positive control sequence
(phox2b-11.2) were present in the identiﬁed G1 founders. Four of the
36 identiﬁed founders contained only the zebraﬁsh phox2b -11.2
sequence and displayed reporter expression as previously reported
[26]; thus 32 ﬁsh remained to be analyzed for ASCL1-consistent
enhancer activity. All seven ASCL1 amplicons were identiﬁed in
transgene-positive G1 embryos displaying reporter expression in
ascl1a/b appropriate tissues, including the telencephalon, dienceph-
alon, midbrain, and hindbrain. The majority of transgene transmitting
embryos displayed reporter expression in hindbrain neuronal
populations (27/32). Similarly the midbrain was marked in 26/32
and the spinal cord in 17/32, consistent with ascl1a/b and ascl1b
respectively and with mammalian ASCL1 orthologs [34]. ASCL1+3.3
was also identiﬁed in offspring from two “founder” G0 zebraﬁsh
displaying expression in the pronephric duct (Supplemental Table 2
and Supplemental Fig. 1). Although not a domain of endogenous Ascl1
expression, this may reﬂect a dual role for this element in the
regulation of neighboring genes in addition to potentially regulating
ascl1. Indeed, the PAH gene encoding phenyalanine hydroxylase,
which lies 40 kb upstream of the human ASCL1 is expressed in the
pronephric duct of embryonic zebraﬁsh [46]. Alternatively this
observation may simply reﬂect the analysis of a sequence out of its
genomic context, consistent with observations in similar transgenic
enhancer studies [23,26,47–49].
Tol2 transposon mediated transgenesis yields single and multiple
independent integrations within the genome of injected embryos
with varying frequency [29]. G1 embryos thus harbor one or more
transgenes that may contribute to the observed reporter expression
and may segregate independently in subsequent generations. Of the
36 identiﬁed G0 “founders”, 16 generated embryos harboring only
one transgene, 12 generated embryos harboring two transgenes, and
offspring from the remaining 8 “founders” had three or more
transgenes each (Supplemental Table 2). Because of the large number
of transgenic zebraﬁsh created we are able to illuminate the regu-
latory potential of ﬁve of the nine regulatory amplicons. Theand dorsal (inset) ﬂuorescent images of GFP expression in 48 hpf zebraﬁsh. All images
ﬁsh line 46 directs expression in the diencephalon, midbrain, and hindbrain. B, The -6.1
zebraﬁsh line 39 directs expression in the diencephalon, midbrain, and spinal cord.
rain, hindbrain, and spinal cord. E, The +13.2 amplicon in zebraﬁsh line 19 directs
piphysis; Di, diencephalon; Hb, hindbrain; arrowheads, rhombomeres of hindbrain;
Fig. 3. in situ hybridization images of endogenous ascl1a and GFP expression. Lateral and dorsal (inset) brightﬁeld images of ascl1a and GFP expression in 24 hpf and 48 hpf zebraﬁsh.
All images oriented with the anterior to the left and posterior to the right. A-D, 24 and 48 hpf lateral and dorsal images of endogenous ascl1a expression. E and F, 48 hpf images of GFP
expression in -6.1 containing zebraﬁsh line 50. G-J, 24 and 48 hpf images of GFP expression in -1.4 containing zebraﬁsh line 39. K, 48 hpf image of GFP expression in +3.3 containing
zebraﬁsh line 10. L-O, 24 and 48 hpf images of GFP expression in +13.2 containing zebraﬁsh line 19. Te, telencephalon; Di, diencephalon; E, epiphysis; Mb, midbrain; Hb, hindbrain;
S, sympathetic ganglia; SC, spinal cord.
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reporter patterns for each construct (independently or in combination
with others) are reported in Table 1 (ASCL1 -7.3, -6.1, -1.4, +3.3,
+13.2; Fig. 3). Images of the 28 transgenic embryos not displayed in
the main text are provided in Supplemental Fig. 1.Table 1
Overview of expression patterns for identiﬁed founders. The ratios of founders
containing a single amplicon displaying GFP expression in speciﬁc tissues over the total
number of founders containing a single amplicon are reported. In parentheses are the
numbers of founders containing multiple amplicons (which also include the given
amplicon) showing GFP expression speciﬁc tissues over the total number of founders
containing multiple amplicons.
Amplicon Telencephalon Diencephalon Midbrain Hindbrain Spinal Cord
-7.3 0/1 (3/8) 1/1 (2/8) 1/1 (7/8) 1/1 (7/8) 0/1 (6/9)
-6.1 1/4 (4/7) 1/4 (2/7) 3/4 (6/7) 2/4 (5/7) 2/4 (3/7)
-1.4 0/2 (3/6) 1/2 (1/6) 1/2 (4/6) 1/2 (5/6) 2/2 (5/6)
-0.4
+3.3 0/4 (4/8) 1/4 (3/8) 4/4 (5/8) 4/4 (8/8) 4/4 (7/8)
+7.0 (4/4) (1/4) (4/4) (3/4) (4/4)
+13.2 0/1 (6/9) 0/1 (2/9) 1/1 (9/9) 1/1 (7/9) 1/1 (5/9)
+19.9
+54.4 (1/1) (0/1) (1/1) (1/1) (1/1)
-11.2 2/4 (6/9) 0/4 (3/9) 1/4 (6/9) 4/4 (9/9) 2/4 (6/9)
Sum⁎ 12/32
[38%]
10/32
[31%]
26/32
[81%]
27/32
[84%]
17/32
[53%]
⁎ Includes all founders except those carrying only the -11.2 amplicon (ﬁsh 26, 56,
62, 79).Two of the nine ASCL1-speciﬁc amplicons were not detected
among transgene positive G1 embryos. This may reﬂect their inability
or failure to direct tissue speciﬁc expression at the times evaluated
and thus were not among those raised or that they do contain
enhancer activity and that an insufﬁcient number of founders were
screened. To eliminate the second possibility, the two amplicons -0.4,
and +19.9 were each re-injected into N200 embryos and screened
independently for mosaic transgene expression at 24, 48, and 72 hpf.
No tissue-speciﬁc expression was detected, suggesting that these
regions do not function as enhancers in the assay. We also note that
the +7.0 and +54.4 amplicons were not present alone in any GFP
positive embryos; to conﬁrm whether or not these amplicons could
direct tissue speciﬁc expression these two were injected indepen-
dently into N200 embryos. None of the embryos assayed between 24
and 72 hpf displayed tissue speciﬁc GFP expression, suggesting that
these two do not contribute to ascl1 transcription as enhancers during
early development.
Of the remaining ﬁve enhancers (ASCL1 -7.3, -6.1, -1.4, +3.3, and
+13.2) all direct ASCL1 consistent expression patterns in embryonic
zebraﬁsh (Table1).Representative images forﬁveof the enhancers (-7.3,
-6.1, -1.4, +3.3, and +13.2) are displayed in Fig. 3. One founder
was identiﬁed for the -7.3 amplicon, which has expression in the
diencephalon, midbrain, and hindbrain (Table 1, Supplemental Fig. 1).
Four independent founders were identiﬁed that integrated
the element -6.1. In total, the four sequences directed expression
across the telencephalon, diencephalon, midbrain, hindbrain, and
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expression in the telencephalon and diencephalon, two or more
showed expression in the midbrain, hindbrain, and spinal cord,
indicating that this sequence has stronger speciﬁcity for the later
tissues. -6.1 was designed to encompass the human ortholog of mouse
Ascl1 Tg14 [42]. This transgene directed expression restricted to the
diencephalon, midbrain, and spinal cord. Variants of Tg14 that
mutated a putative repressor E-box (CAGGTG) directed expression
in a less restricted manner throughout the entire CNS [42]. Our -6.1
amplicon similarly contains this E-box repressor and is also tightly
restricted to ASCL1 tissues (midbrain, hindbrain, spinal cord).
Two founders were identiﬁed containing only the ASCL1-1.4
sequence. These founders showed expression in the diencephalon,
midbrain, hindbrain, and spinal cord with differing frequencies. When
analyzing all founders containing -1.4, most directed expression in the
midbrain, hindbrain, and spinal cord (Fig. 2). However, only 1/6
showed diencephalon-speciﬁc expression, suggesting this expression
domain may not reﬂect endogenous control by this enhancer. By
contrast founders carrying only the +3.3 element show a strong
tendency to direct expression in the midbrain, hindbrain, and spinal
cord, with 4/4 founders showing expression in these tissues. Only one
founder showed expression in the diencephalon.
Finally, the element+13.2 has a single unique founder that directs
expression in the midbrain, hindbrain, and spinal cord. It also has
several founders that contain only +13.2 and phox2b-11.2, the latter
is expressed generally in the ventral anterior spinal cord (Supple-
mental Table 2). This allows for better conﬁdence in seeing whether
+13.2 can direct expression in other tissues. The majority of embryos
with multiple insertions that also contain +13.2 (6/9) direct
expression in the telencephalon, suggesting that this sequence
also contains enhancers who are active in this tissue as well as
conﬁrm expression in the midbrain (9/9), hindbrain (7/9), and spinal
cord (5/9).
In summary, all CNS sites of expression discovered in our 32
transgene founders overlap ASCL1 expression, suggesting they
represent true endogenous ASCL1 enhancers.
In-situ hybridization reveals temporal speciﬁc expression patterns
ASCL1 expression is temporally dynamic and tightly spatially
controlledwithin the developing nervous system.We have previously
seen how enhancers at a single locus can display overlapping spatial
control but discrete temporal control; thus to better determine
whether these enhancers also display temporal-speciﬁc expression in
developing zebraﬁsh we completed GFP in-situ hybridization on four
lines (-6.1, -1.4, +3.3, +13.2, Fig. 3). In situ hybridization of zebraﬁsh
ascl1a, tyrosine hydroxylase (th), and dopamine beta hydroxylase
(dbh), were also performed to provide landmarks that overlap some
sites of ASCL1 expression and would aid in annotating the sites GFP
expression (Supplemental Fig. 2). th is expressed at both 24 hpf and
48 hpf in the diencephalon and locus coeruleus. dbh is expressed at
24 hpf and 48 hpf in the locus coeruleus.
We found that while -6.1 remains inactive at 24 hpf (data not
shown), it directs expression speciﬁc to themidbrain and sympathetic
chain at 48 hpf (Fig. 3A). Similarly, +3.3 also shows no GFP
expression at 24 hpf (data not shown) but directs expression across
multiple ASCL1-speciﬁc tissues at 48 hpf, including the diencephalon
and hindbrain (Fig. 3C). In contrast, the elements -1.4 and +13.3
direct very strong and broad CNS expression at 24 hpf becomingmore
restricted at 48 hpf (Fig. 3B, D). Amplicon -1.4 directs expression in a
large number of ASCL1-speciﬁc tissues, including very strong
expression in the telencephalon, diencephalon, midbrain, hindbrain,
and spinal cord (Fig. 3B). However, at 48 hpf, the expression is tightly
restricted to the telencephalon and locus coeruleus. The element
+13.3 also shows very strong expression at 24 hpf in many tissues
including the telencephalon, diencephalon, midbrain, and hindbrain.At 48 hpf the expression tapers signiﬁcantly to only the epiphysis and
hindbrain (Fig. 3D). Collectively these data suggest that the identiﬁed
enhancers comprise ASCL1 regulatory elements with incompletely
overlapping temporal and spatial control perhaps reﬂecting differing
requirements during development.
Discussion
Transgenesis in vertebrate organisms provides a robust system in
which to evaluate putative noncoding cis-regulatory sequences.
However, the pace at which these animals can be created and
analyzed is readily outpaced by the in silico prediction of potential
regulatory elements. We set out to test a new approach that we hoped
would allow more rapid and comprehensive analysis of a single locus
or many loci. We report a method for pooling constructs for injection
and analysis in germline transmitted zebraﬁsh embryos. Having
previously demonstrated that mammalian regulatory sequences can
be reliably assayed in zebraﬁsh [1,23,25], we chose to apply this
method on the human ASCL1 locus.
We screened 82 potential transgenic founder zebraﬁsh, identifying
32 that transmitted ASCL1-derived constructs and reporting GFP in
their central nervous system in a manner consistent with the
endogenous ascl1a/b orthologs. These enhancer sequences, in sum,
recapitulate almost the entire ASCL1 endogenous expression pattern
in the telencephalon, diencephalon, midbrain, hindbrain, sympathetic
chain, and spinal cord. Control of expression in the midbrain and
hindbrain predominated, suggesting that development of these
neuronal populations may require especially precise control of
ASCL1 expression consistent with the requirement for ascl1 in these
regions, particularly in noradrenergic neurons.We also found reporter
expression in non-ASCL1 speciﬁc tissues, including the heart, and the
pronephric duct in a small number (b5/36) of transgenic lines
(Supplemental Table 2). Some of these expression domains however
may reﬂect additional roles in the regulation of neighboring genes like
PAH, which lies 40 kb upstream of ASCL1 is expressed in the
pronephric duct of embryonic zebraﬁsh or position effect of insertion
[46].
In undertaking this study we tried to improve both the yield and
rate of transgenic analysis in zebraﬁsh. We compare the approaches
and the time required at each step in Supplemental Table 1. The
established mosaic strategies offer a rapid initial screen of regulatory
control, available within days. The resulting data, however, is not
comprehensive and requires the analysis of many representative
embryos, thus signiﬁcantly increasing documentation time in assem-
bling a composite description of regulatory control (Supplemental
Table 1). For a more comprehensive description of developmental
regulatory control one must consider germline transmission-based
analyses. By contrast, although not as immediate as the data
generated in mosaic analyses of individual constructs (Supplemental
Table 1), our approach does have several advantages, including:
increased scaling potential, the ease of raising complex pools of
embryos in common tanks for subsequent identiﬁcation, and the non-
mosaic nature of the resulting analyses. The improvement in
efﬁciencies of scale are clear when one considers larger data sets;
one may inject many more constructs and, somewhat like a
mutagenesis screen, identify the molecular origins of only those
displaying the phenotype (expression pattern) of interest. Using a
PCR-based approach for the identiﬁcation of discrete lines means that
the injected embryos do not need to be raised in separate tanks,
signiﬁcantly reducing the numbers of tanks utilized for this purpose.
Furthermore, moving away from analyses in mosaic embryos to
analyze larger numbers of constructs in germ line transmitted
embryos in our hands has proved to be less prone to subjective
determination of the anatomical location of signal as compared to
analysis in G0 mosaic embryos and also signiﬁcantly reduces time
spent screening for and analyzing reporter expression (Supplemental
368 D.M. McGaughey, A.S. McCallion / Genomics 95 (2010) 363–369Table 1). Real comparisons between these approaches are difﬁcult;
one is trading near immediate data for a pipeline that produces more
comprehensive data on a larger scale.
However, this study has also revealed an additional layer of
complexity; signiﬁcant numbers of zebraﬁsh harbor two or more
transgenes, occasionally complicating analysis. We believe that the
robust nature of this study largely overcomes this issue though the
generation of large numbers of transgene-positive founder zebraﬁsh.
We do, however, feel that in the light of the comparison of these
strategies further improvement is readily attainable. One might
imagine the following: First, the injection of single transgenes into
150-200 zebraﬁsh embryos along with co-population of embryos
from ﬁve ormore other transgene injections for raising in single 5 liter
tank would eliminate the issue of zebraﬁsh containing multiple
transgenes and reduce pressure on facility occupancy. Second, the co-
population of tanks combined with the straightforward PCR/
sequence-based identiﬁcation of transgenes should facilitate efﬁcient
screens of selected loci to identify speciﬁc regulatory phenotypes of
interest. Based on our estimates of a study of 50 constructs, the time
taken in such an approach is the same as that for a similar sized
pooling effort; it retains the analytical advantages of germline
transmission and yet is complimented by the reduced complexity of
single injection-based traditional approaches (Supplemental Table 1).
One may then in theory simply screen through offspring for
expression patterns of interest and sequence the contributing
enhancers post-hoc. We believe that such an approach may prove to
be particularly useful in the validation of large numbers of sequences
identiﬁed through ChIP-Seq assays or the identiﬁcation of biologically
relevant regulatory sequences within intervals implicated in disease
through human association studies. These and other advances will
continue to expand the platform on which functional analyses of
genomic datasets are predicated.Methods
Selection and ampliﬁcation of human noncoding sequence
The sequences studied were in the regions corresponding to
chr12:101,869,373-101,932,015 in the human March 2006 (hg18)
build. Using standard PCR conditions, the ninemost highly constrained
sequences as deﬁned by PhastCons (Supplementary Table S1) were
ampliﬁed off of human genomic DNA and separately subcloned into
the pT2GWcfosEGFP, a Tol2-based transgenic reporter construct
[23,26,45]. We, and others, have previously shown this to be a reliable
screen for enhancer activity [23,45,49].Fish Care
All zebraﬁsh were raised, bred, and staged according to standard
protocols at 28 °C [50,51].Embryo injections and analysis
Putative regulatory elements subcloned into the pT2GWcfosEGFP
reporter construct were injected into wild-type G0 AB zebraﬁsh
embryos [23,45]. Reporter expression directed by each construct was
then evaluated in N1000 live G0mosaic embryos at 24, 48, and 72 hpf.
Approximately 250 zebraﬁsh were selected to be raised to sexual
maturity. 65 males were outcrossed to AB females and the offspring
were screened at 24, 48, and 72 hpf for reporter expression. Analysis
of embryos was conducted using a Carl Zeiss Lumar V12 Stereo
microscope with AxioVision version 4.6 software. Images captured
were further cropped and levels adjusted in Adobe Photoshop CS4.In-situ Hybridization
For the ascl1a, th, and dbh ISH, embryos were collected from
matings of AB zebraﬁsh at 24 and 48 hpf and ﬁxed for ISH using
standard protocols. For the GFP ISH, GFP positive embryos were
collected from the matings of G0 males and AB females. The ascl1a
riboprobe was generated by topo cloning sequence ampliﬁed with the
forward primer ACGACTTGGTTGTTCATGC and the reverse pririmer
GGATCCATTAACCCTCACTAAAGGGAATTGACTGCAACACGTAAAGC off
zebraﬁsh genomic into the vector pCRII-TOPO. The plasmids used to
create the th and dbh riboprobes were created were acquired from,
respectively, Zygogen and Steve Wilson.
Genotyping
DNA was extracted from G1 embryos using standard protocols.
PCRswere done off the genomic DNA using a forward primer designed
off the pT2GWcfosEGFP backbone (CAATCCTGCAGTGCTGAAAA)
while the 10 reverse primers are designed off the 10 unique
sequences being analyzed (Supplemental Table 3). The primers
were tested by their ability to amplify off a mixture of zebraﬁsh
genomic DNA and the appropriate transgene vectors diluted down to
a concentration appropriate for a single insertion.
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